The Wessex Cancer Innovation programme is a two year joint venture between Wessex Academic Health Science Network (Wessex AHSN) and the Wessex Cancer Alliance (WCA) running from December 2020 to December 2022.
It has been developed to identify and support the adoption of innovations that enable teams across Wessex to diagnose cancers at an early stage; a focus which follows the ambitious NHS Long Term Plan aim of diagnosing 75% of cancers at stages 1 and 2 by 2028.
The programme team includes a Clinical Advisor and Programme Manager who work with national and local cancer teams to identify suitable 'ready to go', evidence-based and tested innovations that address local, unmet needs.
To do this, the programme team will:
- build links with local, regional and national teams involved in the diagnosis of cancer and the implementation of innovations
- develop relationships with cancer Site Specific Groups (SSGs) across Wessex
- gather insight to understand which cancers would benefit the most from early diagnosis and map any unmet needs against available and proven innovations
- use the AHSN cancer innovation horizon scan to identify tested and proven innovations adopted by other AHSN/Cancer Alliance teams that may benefit local need
- work with WCA and local cancer leads to establish spread and adoption plan of cancer innovations – including plans on how to identify suitable early adopters, innovation scale up across other relevant teams and longer-term sustainability of innovation adoption
- support the spread and adoption of nationally approved innovations
- enable and support local teams to adopt relevant innovations
- develop metrics to measure and monitor impact of any adopted innovations – including the measure of spread and level of adoption
- support the wider spread of innovations successfully adopted in Wessex with a positive impact to other AHSNs, Cancer Alliances and the national cancer programme team through shared learning.
With links across both Wessex AHSN and WCA, the programme is working closely with the following national and local workstreams:
The programme team will maintain regular communication with each workstream to ensure opportunities for collaboration are identified and utilised.
Stakeholders from the Wessex Cancer Alliance (including patient representatives) and local cancer teams are involved. This includes:
- NHS England and NHS Improvement
- Wessex Prevention and Early Diagnosis board WCA
- Wessex Primary Care Networks
- Wessex Voices (Patient Group)
- Dorset Cancer Partnership
- Site Specific Groups (SSGs)
- Specialist cancer teams
- Pathology teams
If you wish to discuss the programme or want to talk to the programme team, please contact us via the link below.